Innocell™ Cancer Vaccine
Personalized immuno-therapy for solid or liquid tumors.
$133 Billion Market in emerging field of immunotherapy; growing to $200 Billion by 2022
Proof of concept
achieved in animals
2 Pending Utility/Composition of Matter Patents
Cancer causes 1 in 4 deaths in the US. Malignant solid tumors account for over 90% of cases.
Proof of concept achieved in human cancer cell lines
Experienced and capable leadership team